Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Interest-Income" stands at 0.912 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 06/30/2023.
Johnson & Johnson's second quarter result of 0.219 Billion USD for the item "Interest Income" represents a decrease of -4.37 percent compared to it's first quarter result.
Also, Johnson & Johnson's second quarter result of 0.219 Billion USD for the item "Interest Income" represents a decrease of -15.77 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's second quarter result of 0.912 Billion USD for the item "Interest Income" represents a decrease of -4.30 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -21.72 percent compared to the value the year prior.
The 1 year change in percent is -21.72.
The 3 year change in percent is -9.52.
The 5 year change in percent is 1,653.85.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Interest Income | 905,699,262,464.00 |
![]() | AbbVie Inc - Interest Income | 399,570,305,024.00 |
![]() | Roche Holding AG - Interest Income | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Interest Income | 280,205,508,085.11 |
![]() | Novartis AG - Interest Income | 255,096,620,580.91 |